1. Home
  2. TRAK vs PROK Comparison

TRAK vs PROK Comparison

Compare TRAK & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRAK
  • PROK
  • Stock Information
  • Founded
  • TRAK 1990
  • PROK 2015
  • Country
  • TRAK United States
  • PROK United States
  • Employees
  • TRAK N/A
  • PROK N/A
  • Industry
  • TRAK EDP Services
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TRAK Technology
  • PROK Health Care
  • Exchange
  • TRAK Nasdaq
  • PROK Nasdaq
  • Market Cap
  • TRAK 374.5M
  • PROK 384.2M
  • IPO Year
  • TRAK 1998
  • PROK N/A
  • Fundamental
  • Price
  • TRAK $17.19
  • PROK $2.25
  • Analyst Decision
  • TRAK
  • PROK Buy
  • Analyst Count
  • TRAK 0
  • PROK 5
  • Target Price
  • TRAK N/A
  • PROK $6.25
  • AVG Volume (30 Days)
  • TRAK 51.7K
  • PROK 1.7M
  • Earning Date
  • TRAK 09-29-2025
  • PROK 08-12-2025
  • Dividend Yield
  • TRAK 0.42%
  • PROK N/A
  • EPS Growth
  • TRAK 21.41
  • PROK N/A
  • EPS
  • TRAK 0.34
  • PROK N/A
  • Revenue
  • TRAK $22,028,373.00
  • PROK $527,000.00
  • Revenue This Year
  • TRAK $15.18
  • PROK $265.05
  • Revenue Next Year
  • TRAK $10.00
  • PROK N/A
  • P/E Ratio
  • TRAK $50.51
  • PROK N/A
  • Revenue Growth
  • TRAK 9.73
  • PROK N/A
  • 52 Week Low
  • TRAK $15.12
  • PROK $0.46
  • 52 Week High
  • TRAK $25.01
  • PROK $7.13
  • Technical
  • Relative Strength Index (RSI)
  • TRAK 54.59
  • PROK 43.80
  • Support Level
  • TRAK $15.80
  • PROK $2.23
  • Resistance Level
  • TRAK $16.66
  • PROK $2.56
  • Average True Range (ATR)
  • TRAK 0.59
  • PROK 0.16
  • MACD
  • TRAK 0.17
  • PROK -0.02
  • Stochastic Oscillator
  • TRAK 99.72
  • PROK 9.33

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Share on Social Networks: